FIELD: medicine, pharmacy.
SUBSTANCE: invention relates to using a pharmaceutical preparation comprising beta-blocking agent in the maintenance dose less 50 mg, in particular, in the range from 25 mg to 47 mg in mixture with a pharmaceutically acceptable adjuvant, vehicle or carrier. The preparation is used in treatment of atherosclerosis and diseases associated with thereof. Invention provides decreasing dose of the preparation.
EFFECT: improved using method.
6 cl, 3 tbl, 1 ex
Authors
Dates
2006-03-20—Published
2001-06-15—Filed